首页> 外国专利> FETAL DECELLULARIZED NUCLEUS PULPOSUS MATERIAL AND METHODS FOR OBTAINING PHARMACEUTIC COMPOSITIONS TO BE USED IN THE TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND BACK PAIN

FETAL DECELLULARIZED NUCLEUS PULPOSUS MATERIAL AND METHODS FOR OBTAINING PHARMACEUTIC COMPOSITIONS TO BE USED IN THE TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND BACK PAIN

机译:胎儿脱细胞核化的髓核材料和用于获得药物组合物的方法用于治疗椎间盘变性和背部疼痛

摘要

The present invention refers to the use of a fetal-origindecellularized nucleus pulposus (NP) allogenic material to regenerate a host's Intervertebral Disc (IVD).In particular, the present invention refers a decellularized NPmaterial, obtained from a vertebrate fetus and characterized by comprising high levels of collagen 12 and 14, in a pharmacological composition to be used in the treatment of IVD degeneration.The invention is based on the increased ability of the said fetal decellularized NP material to stimulate the host constituent cell's to increase the expression of collagen 2 and aggrecan, promoting intrinsic IVD regeneration.The present invention further refers to the methods for preparing the said pharmaceutical compositions of fetal decellularized material in the form of fragments/microparticles and hydrogel for an injectable mode of administration.The use, material, pharmaceutical compositions and methods of the present invention may be advantageously used for the prevention and treatment of IVD degeneration and back pain in human and veterinary settings.
机译:本发明涉及使用胎儿源细胞化髓核(NP)同种异体材料来再生宿主的椎间盘(IVD)。特别地,本发明是指从脊椎动物胎儿获得的脱细胞的NPM材料,其特征在于包含高分子在用于治疗IVD变性的药理组合物中胶原12和14的水平。本发明基于所述胎儿脱细胞的NP材料刺激宿主成分细胞的能力增加,以增加胶原2的表达促进内在IVD再生的藻康。本发明进一步是指以碎片/微粒和水凝胶的形式制备胎儿脱细胞材料的所述药物组合物的方法,用于可注射给药方式。使用,材料,药物组合物和方法本发明可以有利地用于预防n和人类和兽医环境中IVD退化和背部疼痛的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号